Physician

Bret Robert Adams, MD, PHD

According to 2025 Medicare claims, Bret Adams, MD, PHD (NPI: 1891056495) practices radiation oncology in the Roanoke, VA market, with the plurality of this provider's patient population coming from Roanoke City, VA. This provider's primary affiliated billing organization is ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (NPI: 1487621496; TIN: 541922084) and primary practice location at 24014-1838. Adams is affiliated with the Doctors Connected (ACO ID: A4949), participating under the MSSP model.

Adams' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 562 traditional Medicare patients, billed 4,622 HCPCS/CPT codes, and received $350,810 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 700 prescription claims across 238 beneficiaries totaling $34,436 in drug costs, led by Lidocaine Hcl Viscous (Lidocaine Hcl). DME data shows 12 claims. Open Payments data shows 2 records totaling $58. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $114,812 to $350,810. Similarly, Part D prescription costs have moved sharply higher in recent years, from $2,690 to $34,436. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	223	1,628	$114,812
2018	330	2,862	$203,239
2019	468	3,673	$259,492
2020	485	4,071	$285,046
2021	528	5,499	$379,733
2022	552	4,753	$325,079
2023	541	5,386	$371,788
2024	562	4,622	$350,810

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	42	87	$2,690
2018	108	243	$9,028
2019	156	453	$19,218
2020	172	521	$20,706
2021	194	597	$24,056
2022	220	798	$51,078
2023	222	730	$24,371
2024	238	700	$34,436

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	14	$1,102
2019	N/R	26	$2,672
2020	N/R	27	$2,784
2021	N/R	11	$1,921
2022	N/R	55	$6,175
2023	N/R	32	$5,360
2024	N/R	12	$2,196

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	157	444	$144
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	133	133	$129
77263	Complex radiation therapy planning	147	156	$125
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	159	195	$43
77014	Ct guidance for insertion of radiation therapy fields	145	1,334	$39

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lidocaine Hcl Viscous	Lidocaine Hcl	65	606	$1,760
Mometasone Furoate	Mometasone Furoate	91	2,094	$1,738
Tamsulosin Hcl	Tamsulosin Hcl	55	2,910	$645
Oxycodone Hcl	Oxycodone Hcl	47	751	$577
Sucralfate	Sucralfate	12	280	$558

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4152	Enteral formula, nutritionally complete, calorically dense (equal to or greater than 1.5 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit	N	N/R	12	$2,196

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$58	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bret Robert Adams, MD, PHD?

Tedicare shows public-source Medicare data for Bret Robert Adams, MD, PHD (NPI 1891056495), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bret Robert Adams, MD, PHD have ACO affiliation data?

Bret Robert Adams, MD, PHD is shown with ACO affiliation data for Doctors Connected (MSSP, ACO ID A4949).

What billing organization is linked to Bret Robert Adams, MD, PHD?

Bret Robert Adams, MD, PHD is linked to ONCOLOGY AND HEMATOLOGY ASSOCIATES OF SOUTHWEST VIRGINIA, INC. (billing NPI 1487621496) in the available physician profile data.

Does Bret Robert Adams, MD, PHD have Open Payments data?

Bret Robert Adams, MD, PHD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.